Abstract
The JCVI held a second extraordinary meeting on vaccines for SARS-CoV-2 (COVID-19), looking at:
- Review of epidemiological data
- COVID-19 sero-epidemiology
- Delivery of candidate COVID-19 vaccines
- Influenza programme – considering COVID-19
- Risk factors for serious disease and mortality
- Vaccine platforms
- Vaccine development update
- Immune responses to infection
Agenda & Minutes
Europe
United Kingdom
COVID-19
Influenza
